PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells - Wikidata - wikimedia - TriplyDB

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

http://www.wikidata.org/entity/Q24677367

about

Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells Regulation of Th2 Cell Immunity by Dendritic Cells Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy Adaptive Immune Resistance: How Cancer Protects from Immune Attack Role of the PD-1 pathway in the immune response Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review Ly6C(high) monocytes become alternatively activated macrophages in schistosome granulomas with help from CD4+ cells The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1 Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily The role of the PD-1 pathway in autoimmunity and peripheral tolerance Lipidoid Nanoparticles Containing PD-L1 siRNA Delivered In Vivo Enter Kupffer Cells and Enhance NK and CD8(+) T Cell-mediated Hepatic Antiviral Immunity.Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability.A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice.PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct.Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model.Similarity and diversity in macrophage activation by nematodes, trematodes, and cestodes.Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer.Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation.Immunogenicity and immunomodulatory effects of the human chondrocytes, hChonJ.PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.Yin-Yang of costimulation: crucial controls of immune tolerance and function.Control of macrophage activation and function by PPARs.Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke.Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274).Th2 cell-intrinsic hypo-responsiveness determines susceptibility to helminth infection Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10 Mutation-specific control of BCR-ABL T315I positive leukemia with a recombinant yeast-based therapeutic vaccine in a murine model A novel function for programmed death ligand-1 regulation of angiogenesis L2pB1: a new player in autoimmunity.Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice Systemic impact of intestinal helminth infections.PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndrome.

P2860

Q24682128-4BAC9DBD-3518-40FB-8C8C-F356DDF4ED56 Q24796946-63D2D93F-D9FC-48FC-A87B-CC0C9065A9BF Q26764869-0227B0C0-ED5B-4683-A2F8-D42A3478CD13 Q26781481-4C3CEDE1-F097-40C3-9157-7853D4839A65 Q26798448-4B197123-A5BA-4A4B-80B9-1175EA722D5C Q26828748-53100A22-2CE2-41B5-B633-C531DD73D8FF Q27304386-CCFBA5AC-828E-40FF-A3AD-20DB1AB09649 Q27328478-BF0ABC1B-4DD8-4217-A592-A957C70F4C6A Q28069924-B5856201-1F4B-4B3F-9703-2808600ABAEA Q28271806-942C789D-3466-404D-9E07-5A61E16504F2 Q28304161-97D06249-2629-4439-9B9A-C6DD89F34886 Q30422001-03F679D2-28FE-41FA-8B0A-134FE3EEDBE4 Q30480631-8AB0F49C-E79D-4B70-8C70-E0A2A598FF96 Q30934051-62D64185-431B-4F16-A5C9-45EF1DDD5EED Q33275412-3A0D3E7C-1348-429A-84FD-302B6087C84C Q33621624-827E0D9E-8D6A-4BD8-8532-92B97432C868 Q33631222-2F6002CC-E565-41E4-B880-106BEECE57B3 Q33633305-A1C418C3-93F9-4F5C-A560-32CAC9F4CC9C Q33648621-959033D5-4E6A-4756-BB9D-437E64815F40 Q33675737-2F1E8A55-E757-4320-8A02-17B766601492 Q33706923-60519FBF-7AC9-43DC-A088-F81FB96E26D4 Q33753894-24156D69-9CAF-4264-8961-D0FC3DD41DD3 Q33823290-5610DCAD-CF28-4C1A-8E16-51B470002B33 Q33872168-F2EF5A8B-9FD0-4B53-BC1B-2A94D860197A Q33962601-ADA8A900-4983-407F-B878-D08D6D9AFD72 Q34024724-52CE184E-333E-44BF-A321-00D5CEF13D5F Q34044797-BD8CDE02-B954-4679-8BC1-2F895AE2F459 Q34080755-B5612935-A0AD-4712-8831-08D9D5D66AA6 Q34141476-BD5793F9-4069-439F-B143-DA57E007F486 Q34149169-D2130DEB-E511-45E0-A678-9AB0DE528F22 Q34484749-C4753E1F-E90D-4236-B269-DCF691DC25FB Q34629159-3DDEC41B-F8EB-4D7A-B441-4EBE07CB3790 Q34683647-63FFE8D2-8184-4F2F-9FC6-48082A4178A1 Q34734850-831B83DD-0BA1-43C2-BD2C-FEDB38126FE5 Q34805624-0F3BB5B3-1E0F-43F0-88A6-420D57D4C5B2 Q34927610-4D66CA8D-DFD9-43B9-8313-1D441BFB26DD Q35142813-E9D4D283-AB32-467A-9506-89D90F343724 Q35148851-C70A25B4-570E-48E7-B8C1-ADF1F7E064C9 Q35201893-925ACD0C-514B-4DC7-9028-1FCDC9636C4B Q35531947-466A164F-C07D-4DC5-84A0-8D9FA6144D9C

P2860

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

http://www.wikidata.org/entity/Q24677367

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

@ast

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

@en

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

@nl

type

label

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

@ast

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

@en

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

@nl

prefLabel

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

@ast

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

@en

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

@nl

P1433

Q24677367-BE4DFBFA-4F6A-4D78-A423-CD5D748AEEB4

P1476

Q24677367-7BB3CE5D-963A-4B2D-8083-A3D015FCDFBA

P2093

Q24677367-0446A15E-14AB-450A-A7E7-0D120A43A868

P2860

Q24677367-0688DCD2-CF8B-4086-962B-7EA0E7C2731D

Q24677367-184ABFCF-AFC3-4BB2-8892-3046B5D53BE3

Q24677367-244C8FAB-6B62-4A3D-A207-2B3060DF8430

Q24677367-2A5412A3-1FC5-4700-B9BF-604A54470FCB

Q24677367-3154B201-B58D-41F4-96CD-FA5C35582B1F

Q24677367-33A4A6DA-54EF-4369-97C5-40E54F067575

Q24677367-35EC4612-9313-44B9-BE1A-2F8A2D946505

Q24677367-361D55B7-C1E2-46A0-B1F2-FC292BFD787F

Q24677367-39C0D3C6-3175-45EC-A95F-D339DE41CA0E

Q24677367-4D4917BC-41D5-4E5F-9FC6-0F6948AABCB3

P304

Q24677367-9D0162BD-DDE7-436A-8268-EF56030DE260

P31

Q24677367-14FC3D38-F1B7-4BDE-B181-00E413045C25

P3181

Q24677367-45A2C872-8686-4FC7-8431-E619827AD518

P356

Q24677367-C2AFF2C4-3BD6-4853-AF67-A219E22A2C9A

P407

Q24677367-44A0C6E4-4FD4-4D2C-8ED8-450143686332

P433

Q24677367-EA960259-C747-4F5E-B8E5-50245675DA27

P478

Q24677367-269CE526-03C5-43DF-83DD-8D1B2408FE45

P50

Q24677367-14645D9E-71EC-46EA-AC91-E8A0F935B2D0

P577

Q24677367-037FFA36-13C1-46F0-B7E2-0D1EC60936A2

P5875

Q24677367-EF2056DC-5ED1-40D1-A3FC-FFD36CC9C46F

P698

Q24677367-EBD26CAB-BDDD-4AF6-8F71-764DBB8C8819

P932

Q24677367-CC661C13-BB8F-4B06-8AB5-B51D8B329996

P3181

P356

PNAS.0931259100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

@en

P2093

P'ng Loke

http://www.w3.org/2001/XMLSchema#string

P2860

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Innate immune recognition

Alternative activation of macrophages

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

The IL-4 receptor: signaling mechanisms and biologic functions

P304

5336-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2143421

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0931259100

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

James P. Allison

P577

2003-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10802344

http://www.w3.org/2001/XMLSchema#string

P698

12697896

http://www.w3.org/2001/XMLSchema#string

P932

154346

http://www.w3.org/2001/XMLSchema#string